Clinical Research Directory
Browse clinical research sites, groups, and studies.
Rectosigmoid Lesion Excision vs. Resection: A Non-Inferiority Randomized Comparison in Advanced Ovarian Cancer
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Summary
Colorectum is the most common site of metastasis in ovarian cancer. Regarding intestinal surgery, there is controversy over whether to choose bowel resection or tumor removal, and currently, there are no prospective randomized controlled studies comparing the oncological safety of these two surgical approaches. This study is a prospective randomized trial aimed at comparing the efficacy of rectosigmoid resection versus rectosigmoid-preserving lesion excision in advanced ovarian cancer surgery.
Official title: A Prospective Randomized Controlled Non-Inferiority Study Comparing the Efficacy of Lesion Excision Versus Rectosigmoid Resection in Pelvic Cytoreductive Surgery for Advanced Ovarian Cancer
Key Details
Gender
FEMALE
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
300
Start Date
2024-01-10
Completion Date
2028-12-31
Last Updated
2026-06-01
Healthy Volunteers
No
Conditions
Interventions
Rectosigmoid Lesion Excision +tumor cell debulking surgery
Surgery for pelvic rectosigmoid tumors
Rectosigmoid Resection +tumor cell debulking surgery
Rectosigmoid Resection +tumor cell debulking surgery
Locations (1)
Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China